HomeALDX • NASDAQ
add
Aldeyra Therapeutics Inc
Previous close
$3.94
Day range
$3.86 - $4.05
Year range
$1.42 - $11.97
Market cap
231.17M USD
Avg Volume
706.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.10M | -55.48% |
Net income | -4.75M | 63.16% |
Net profit margin | — | — |
Earnings per share | -0.08 | 63.64% |
EBITDA | -6.03M | 55.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 142.82M | -18.06% |
Total assets | 148.33M | -18.18% |
Total liabilities | 28.53M | -5.78% |
Total equity | 119.80M | — |
Shares outstanding | 58.90M | — |
Price to book | 1.95 | — |
Return on assets | -10.31% | — |
Return on capital | -11.10% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.75M | 63.16% |
Cash from operations | 500.44K | 104.46% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -1.01M | — |
Net change in cash | -511.87K | -103.25% |
Free cash flow | -7.19M | -146.09% |
About
Founded
2004
Headquarters
Website
Employees
10